🦠Why isn’t there a vaccine against the current Bundibugyo #Ebola outbreak in DRC & Uganda?
💉Centre Co-Director Dr Afolabi answers key questions & explains the challenges of developing a vaccine against this strain of Ebola.
Read the Q&A👉https://t.co/NLOpyExyLe
How’s your Friday going?
We’re wrapping up the week by welcoming new leadership at our AMR Centre😍
Excited for what’s ahead in the fight against antimicrobial resistance 👇
https://t.co/iCMKUq0fd3
📢#AMR is a growing global threat that undermines decades of medical progress.
In this blog, India's Prime Minister, @narendramodi, emphasises the urgent need for action to curb misuse and strengthen health systems to tackle #AMR.
Read more: https://t.co/qP164fH8DZ
Kicking off the New Year with £850k funding from @BBSRC to investigate how C. jejuni survives and causes disease.
The project will be led by @OzanGundogdu11 and his team @lshtm and colleagues from @QMUL and @iiserkol
Read more👇
https://t.co/YIuhncpjlI
New study led by Dr @EFosterNyarko in Microbial Genomics finds high antibiotic resistance in cholera bacteria across Africa.
Sequencing by @PulsenetA90250 trainees shows urgent need for stronger genomic surveillance.
Read more: https://t.co/fl6XynC8aC
📢 Applications are open for the MRC London Intercollegiate DTP Studentships!
@LSHTM & @CityStGeorges are offering PhD projects in Global Health, Health Data Science, Translational & Implementation Research, and Infectious Disease.
🗓️ Apply by 14 Jan
👉 https://t.co/p3jwwlYrkJ
Join us for LSHTM’s Equity in AMR Action seminar, which explores how equity influences responses to AMR.
Speakers will share their work from the WHO, LSE, and the Global Strategy Lab.
📅 12 Dec
⏲️ 13:00 GMT
Check the event details 👇
https://t.co/xOwNUo5LVE
From sewage to soil: More monitoring and evidence is needed to understand how environmental resistance is fueling antimicorbial restistance.
Read about stakeholders' perspectives of the UK National Action Plan.
👉 https://t.co/Z5AcHDV7IS
Join us on 26 Nov 2025 for the NeoNET AFRICA & KlebNET-GSP seminar on Klebsiella genomics and neonatal sepsis.
Our Co-Director Prof Kathryn Holt will speak on serotype prevalence & vaccine coverage
⏰ 15:00–16:00 SAST
🔗 https://t.co/xRPKiNHY0t
Antimicrobial Resistance Awareness Week wraps up today — and LSHTM is driving change.
Rebecca Glover’s research is transforming the AMR National Action Plan from strategy into real-world impact, targeting resistance where it matters most.
Read more: https://t.co/0CzyLuDlob
Every hour counts in sepsis. @UduakOkomo explains why timely care is key to saving lives.
Learn more with @JHenryC on the facts and actions to tackle sepsis.
Read more: https://t.co/FNsVyx0qxd
Today is #InternationalMensDay 🤗
Tune into an insightful discussion with @timjcshand and Peter Baker from @GlobalMenHealth unpacking men’s limited representation in regional and global SRH policy, and why it matters. 🎙️
🎧https://t.co/tDP6Yrwfjn
🎉LSHTM #1 in the UK for #PublicHealth for 9th year running in the 2025 @ShanghaiRanking
We have also been ranked #3 in the world for public health in recognition of our prestigious research & study programmes in public and #GlobalHealth🌍
https://t.co/JCinASbRAM
Building local expertise is key to fighting AMR.
Our short course trains scientists and healthcare professionals from around the world.
Register your interest for 2026👉https://t.co/xjpT65eaWG
Antimicrobial Resistance Awareness Week starts today.
Our research themes show how we tackle AMR from every angle, from biological and clinical sciences to modelling, social science, and more.
Learn more: 👉https://t.co/7tkkEjrrqK
Ahead of #WAAW2025, learn how our researchers are tackling AMR across 30 countries globally, spanning biology, clinical science, policy, modelling, and social sciences.
Stay updated on our research, insights, & AMR action.
Sign up for our newsletter: https://t.co/QrZL30Pffj
Rate of drug-resistant bloodstream infections expected to climb in Europe.
In @euronews Gwen Knight explains age & sex thought to have significant impact on those most affected by rise in antimicrobial resistance. @LSHTM_AMR
https://t.co/9wSqXRJ2E5
New #malaria drug promises to beat resistant strains
In @FT, Michael Delves comments on first new anti-malaria treatment for a generation & says it gives reassurance we can continue to save lives if artemisinins fail.
https://t.co/I69swxD8Xt